Yonghong Xiao

Yonghong Xiao has extensive experience in the field of computational biology and data science. Their most recent role was as the Director of Computational Biology at Maze Therapeutics. Prior to that, they founded and served as the Principal Consultant at Yonghong Xiao Data Science Consulting. Yonghong also held positions as the Executive Director of Data Science and Bioinformatics at H3 Biomedicine, the Sr. Director of Quantitative Translational Science at Genospace / Sarah Canon Research Institute, the Director of Bioinformatics at TESARO / GSK, and the Associate Director of Computational Biology at Epizyme. Yonghong Xiao has also worked as a Principal Scientist at AstraZeneca R&D Boston, the Associate Director of Computational Biology at Dana-Farber Cancer Institute, the Group Leader of Target Discovery at Lion Bioscience Research Inc., and as a Senior Scientist at Variagenics Inc. Throughout their career, they have demonstrated leadership and expertise in both target discovery and cancer genomics.

Yonghong Xiao's education history is as follows:

- From 1980 to 1987, they studied Medicine at Peking Union Medical College in China and received an MD equivalent degree.

- In 1987, they pursued a Master of Science (MS) in Biology at the University of South Carolina for two years.

- From 1989 to 1994, they attended the Boston University School of Medicine, where they earned a PhD in Biochemistry and Molecular Biology.

- Subsequently, from 1997 to 2004, Yonghong Xiao obtained a Post Graduate Certificate in Software Engineering from the Harvard University Extension School.

- There is no information available regarding their degree or field of study at Peking University.

- Yonghong also obtained a certification named "Designing and Implementing AI Solutions for Health Care" from Harvard Medical School Executive Education in June 2022.